FDA & Regulatory
Complete Response Letter
A Complete Response Letter (CRL) is the FDA’s notice that it will not approve a drug in its current form, listing the deficiencies that must be resolved. A CRL is not a permanent rejection, but it typically delays approval by months to years and often triggers a sharp stock decline.
- Category
- FDA & Regulatory
- Abbreviation
- CRL
Prepared research question
How does Complete Response Letter affect the view of a biotech company in practice?
Traceable citations · Unknowns marked
A Complete Response Letter (CRL) is the FDA’s notice that it will not approve a drug in its current form, listing the deficiencies that must be resolved. A CRL is not a permanent rejection, but it typically delays approval by months to years and often triggers a sharp stock decline.
Related terms
Learn more
From term to thesis rule
Investigate how Complete Response Letter changes a biotech thesis
Define when Complete Response Letter should count, block, or trigger a deeper check; BioSniper will compile that logic against available evidence.